Why we would stick with hvivo despite share price fall

Drug bust-up: Novo Nordisk is to end its partnership with Hims & Hers Health after less than two months owing to the latter’s sale and promotion of cheap knock-offs of the weight-loss drug Wegovy, say

Past performance is not a reliable guide to the future. However, investors’ portfolios can benefit from UK shares that have consistently and substantially outperformed the stockmarket. One of the best

From AI to goodbyes, and from music to the ear to a poke in the eye

In the world of bonds and fixed income, US billionaire Howard Marks is a titan. After making a name for himself at Citicorp in the 1970s and then TCW Group in the 1980s trading distressed bonds, he fo

Trend-setting health tech In a stressful period in 2021, Tom Hale was having trouble sleeping. He bought an Oura Ring, the pioneering smart device that tracks stats about sleep and health, and made a

Companies in the news ...and how they were assessed